ADENOSINE
NDC 51662-1450, ADENOSINE, injection, solution, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1450
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077133
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE3 mg/mL
Pharmacologic classes
Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1450-3 | 51662145003 | 10 POUCH in 1 CASE (51662-1450-3) / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1450-2) / 4 mL in 1 VIAL, SINGLE-USE (51662-1450-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/996fc80e-b680-31f1-e053-2995a90aa0f1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51662-1450
Use it
Look up 51662-1450 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1450 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1450. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.